IMC Chicago
VRTX icon

IMC Chicago’s Vertex Pharmaceuticals VRTX Stock Holding History

IMC Chicago’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3M Sell
69,100
-8,000
-10% -$3.55M 0.01% 773
2026
Q1 		$34.4M Sell
77,100
-21,000
-21% -$9.79M 0.01% 635
2025
Q4 		$44.5M Buy
98,100
+25,600
+35% +$11M 0.02% 528
2025
Q3 		$28.4M Buy
72,500
+59,100
+441% +$24.7M 0.01% 642
2025
Q2 		$5.97M Sell
13,400
-14,000
-51% -$6.45M ﹤0.01% 1280
2025
Q1 		$13.3M Sell
27,400
-43,500
-61% -$20.3M 0.01% 756
2024
Q4 		$28.6M Buy
70,900
+52,500
+285% +$24.3M 0.01% 488
2024
Q3 		$8.56M Buy
18,400
+1,600
+10% +$769K ﹤0.01% 896
2024
Q2 		$7.87M Sell
16,800
-21,700
-56% -$9.42M ﹤0.01% 874
2024
Q1 		$16.1M Sell
38,500
-24,900
-39% -$10.5M 0.01% 536
2023
Q4 		$25.8M Buy
63,400
+22,100
+54% +$8.16M 0.02% 394
2023
Q3 		$14.4M Sell
41,300
-2,500
-6% -$874K 0.01% 456
2023
Q2 		$15.4M Sell
43,800
-3,400
-7% -$1.15M 0.01% 414
2023
Q1 		$14.9M Buy
47,200
+7,100
+18% +$2.13M 0.02% 399
2022
Q4 		$11.6M Buy
40,100
+17,600
+78% +$5.36M 0.02% 433
2022
Q3 		$6.51M Buy
+22,500
New +$6.47M 0.01% 517
2022
Q2 		– Sell
-11,700
Closed -$3.05M – 1185
2022
Q1 		$3.05M Buy
11,700
+1,000
+9% +$237K ﹤0.01% 665
2021
Q4 		$2.35M Sell
10,700
-7,600
-42% -$1.48M ﹤0.01% 777
2021
Q3 		$3.32M Buy
+18,300
New +$3.57M ﹤0.01% 720
2021
Q1 		– Sell
-10,200
Closed -$2.41M – 1194
2020
Q4 		$2.41M Buy
+10,200
New +$2.34M ﹤0.01% 696
2019
Q1 		– Sell
-4,900
Closed -$812K – 908
2018
Q4 		$812K Buy
+4,900
New +$849K ﹤0.01% 492

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

IMC Chicago's VRTX Position: Q2 2026 in Review

IMC Chicago sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 4,533 shares — an estimated $2.01M sold.

IMC Chicago first reported a position in VRTX in Q1 2026 and held it in 1 quarter. The position peaked at $2.02M in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • IMC Chicago reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 4,533 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.01M.
  • IMC Chicago first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • IMC Chicago's Vertex Pharmaceuticals position peaked at $2.02M in Q1 2026.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.